The authors report a case of a 58 years-old, hypertensive, diabetic female patient, with the diagnosis of American cutaneous leishmaniasis, undergoing treatment with Nmethyl glucamine antimoniate (15mg SbV/Kg/day). She was followed up by the basic health care service, but has died on the 18th treatment day.
Antimony; Death; Drug toxicity; Leishmaniasis, cutaneous; Primary health care